AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 252 filers reported holding AMICUS THERAPEUTICS INC in Q1 2024. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $12,858,651 | -16.9% | 1,296,235 | -1.3% | 0.05% | -15.8% |
Q1 2024 | $15,469,143 | +48.3% | 1,313,170 | +78.7% | 0.06% | +39.0% |
Q4 2023 | $10,427,763 | +1924.8% | 734,867 | +1432.5% | 0.04% | +1266.7% |
Q2 2022 | $515,000 | +20.3% | 47,952 | +6.0% | 0.00% | +50.0% |
Q1 2022 | $428,000 | -86.2% | 45,246 | -83.1% | 0.00% | -88.2% |
Q4 2021 | $3,094,000 | -46.0% | 267,846 | -55.3% | 0.02% | -54.1% |
Q3 2021 | $5,729,000 | -36.7% | 599,845 | -36.1% | 0.04% | -41.3% |
Q2 2021 | $9,049,000 | -48.0% | 938,732 | -46.7% | 0.06% | -50.4% |
Q1 2021 | $17,407,000 | +354.7% | 1,761,865 | +962.7% | 0.13% | +296.9% |
Q4 2020 | $3,828,000 | +194.7% | 165,793 | +80.2% | 0.03% | +190.9% |
Q3 2020 | $1,299,000 | -8.8% | 91,996 | -2.6% | 0.01% | -31.2% |
Q2 2020 | $1,425,000 | +67.6% | 94,475 | +2.8% | 0.02% | -33.3% |
Q1 2020 | $850,000 | -84.4% | 91,945 | -74.6% | 0.02% | -80.3% |
Q3 2017 | $5,466,000 | +80.2% | 362,440 | +20.4% | 0.12% | +60.5% |
Q2 2017 | $3,033,000 | – | 301,143 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fairmount Funds Management LLC | 1,315,395 | $30,372,000 | 10.86% |
Palo Alto Investors LP | 7,867,114 | $181,652,000 | 9.52% |
Perceptive Advisors | 25,112,048 | $579,837,000 | 6.22% |
Redmile Group, LLC | 20,620,490 | $476,127,000 | 5.76% |
Avoro Capital Advisors LLC | 9,000,000 | $207,810,000 | 3.58% |
Ghost Tree Capital, LLC | 600,000 | $13,854,000 | 3.09% |
SECTORAL ASSET MANAGEMENT INC | 1,534,604 | $35,434,000 | 2.50% |
CM Management, LLC | 90,000 | $2,078,000 | 1.93% |
Boxer Capital, LLC | 2,325,000 | $53,684,000 | 1.73% |
Hood River Capital Management LLC | 2,204,140 | $50,894,000 | 1.68% |